Osteoporosis is a complication of androgen deprivation therapy (ADT) in men with prostate carcinoma. This is a multicenter, randomized, double-blind prospective study on use of Denosumab versus Alendronate in the therapy of secondary osteoporosis related to ADT.
Treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients. A prospective randomized multicenter international study with Denosumab Vs Alendronate / Doria, Carlo; Mosele, Giulia R; Solla, Federico; Maestretti, Gianluca; Balsano, Massimo; Scarpa, Roberto M. - In: MINERVA UROLOGICA E NEFROLOGICA. - ISSN 0393-2249. - 69:3(2017), pp. 271-277.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Titolo: | Treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients. A prospective randomized multicenter international study with Denosumab Vs Alendronate | |
Autori: | ||
Data di pubblicazione: | 2017 | |
Rivista: | ||
Citazione: | Treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients. A prospective randomized multicenter international study with Denosumab Vs Alendronate / Doria, Carlo; Mosele, Giulia R; Solla, Federico; Maestretti, Gianluca; Balsano, Massimo; Scarpa, Roberto M. - In: MINERVA UROLOGICA E NEFROLOGICA. - ISSN 0393-2249. - 69:3(2017), pp. 271-277. | |
Abstract: | Osteoporosis is a complication of androgen deprivation therapy (ADT) in men with prostate carcinoma. This is a multicenter, randomized, double-blind prospective study on use of Denosumab versus Alendronate in the therapy of secondary osteoporosis related to ADT. | |
Handle: | http://hdl.handle.net/11388/166882 | |
Appare nelle tipologie: | 1.1 Articolo in rivista |